Postradiation Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer

Postradiation metabolic tumor volume is an adverse prognostic factor in head-and-neck cancer. Biomarkers such as MTV are important for risk stratification and will be valuable in the future with risk-adapted therapies.